Template:Trandolapril: Difference between revisions

Latest revision as of 20:46, 18 February 2014

Trandolapril
MAVIC^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Trandolapril
ClinicalTrials.gov

@@ Line 1: / Line 1: @@
 {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
-! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Trandolapril|{{fontcolor|#6C7B8B|Ramipril}}]]'''''
+! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Trandolapril|{{fontcolor|#6C7B8B|Trandolapril}}]]'''''
 |-
 ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | MAVIC<sup>®</sup> FDA Package Insert
@@ Line 7: / Line 7: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Trandolapril dosage and administration|Dosage and Administration]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Trandolapril dosage forms and strengths|Dosage Forms and Strengths]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Trandolapril contraindications|Contraindications]]
@@ Line 25: / Line 23: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Trandolapril clinical pharmacology|Clinical Pharmacology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Trandolapril nonclinical toxicology|Nonclinical Toxicology]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Trandolapril clinical studies|Clinical Studies]]